Subjective well-being in early-phase schizophrenia patients using long-acting injectable vs. oral antipsychotic drugs: data from the European Long-acting Antipsychotics in Schizophrenia Trial (EULAST)
Eur Psychiatry. 2025 Aug 19:1-30. doi: 10.1192/j.eurpsy.2025.10086. Online ahead of print. NO ABSTRACT PMID:40826928 | DOI:10.1192/j.eurpsy.2025.10086